Duckworth Leads Letter Calling on Walgreens to Clarify that Mifepristone Dispensing Decisions Remain Undecided and Premature as it Seeks FDA Certification
March 09, 2023
March 09, 2023
WASHINGTON, March 9 -- Sen. Tammy Duckworth, D-Illinois, issued the following news release and letter:
U.S. Senator Tammy Duckworth (D-IL) led eleven colleagues in sending a letter to Walgreen's CEO Rosalind Brewer to express strong opposition to Walgreens' premature decision to publicly declare its intent to avoid dispensing Mifepristone--a FDA-approved medication for termination of pregnancy and used to treat miscarriages--in certain states. The letter also urges the com . . .
U.S. Senator Tammy Duckworth (D-IL) led eleven colleagues in sending a letter to Walgreen's CEO Rosalind Brewer to express strong opposition to Walgreens' premature decision to publicly declare its intent to avoid dispensing Mifepristone--a FDA-approved medication for termination of pregnancy and used to treat miscarriages--in certain states. The letter also urges the com . . .